MycoWorks Stock

MycoWorks is a biotech company that delivers commercially viable non-plastic and non-animal materials to the market.

Sign up today and learn more about MycoWorks Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About MycoWorks Stock

MycoWorks is engaged in the creation of sustainable design solutions with advanced biomaterials. The company’s proprietary custom-engineered material is sustainable, versatile, and animal-free, and feels and performs like leather. Their first product, Reishi, and the proprietary platform to make it, Fine Mycelium, are a groundbreaking approach to biomaterials that delivers unparalleled versatility and unmatched performance in strength, durability, and hand feel. The perfect intersection of art and science, Reishi is the only natural material that performs like cowhide leather and is engineered to meet the highest quality standards. MycoWorks was founded by Sophia Wang and Philip Ross in 2013 and is based in Emeryville, California.

Funding History

February 2020$17.0M
October 2020$45.0M

Management

CEO

Matthew Scullin

Co-Founder & Chief of Staff and Culture

Sophia Wang

CTO

Philip Ross

Senior Vice President, Sales and Business Development

Frederick Martel

VP of People

Kimberly Saunders

Brand Consultant

Eliana Gallego

COO

Mike Lindheim

Advisor

Christopher E. Griffin

Quality Lead

Rachel Foote

Investor

Paul Straub

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo